GRIDS

Genetic, Rare & Immune Disorders Symposium

Image

JOiN US! for GRIDS November 18-19, 2018

Lysosomal Storage Disorders (LSDs) are a group of Rare Diseases, each of which is caused by the deficiency of a lysosomal enzyme or an essential cofactor leading to deposition of the substrate within the lysosomes, resulting in cellular and tissue dysfunction. Therapies are now available for multiple LSDs with published guidelines for monitoring, treatment and clinical outcome measures. However, there is a high variability in presentation, clinical onset and course for any given LSD. It is now understood that late/adult onset and attenuated forms exist for several LSDs, including Pompe disease, Gaucher disease, Fabry disease, Tay-Sachs disease and Mucopolysaccharidoses (MPS). With newer genomic techniques, more patients are diagnosed later in life and/or with ‘not so typical’ presentations. This workshop will focus on basic mechanisms, varied clinical phenotypes and establishing goals for disease monitoring and various treatment strategies for late onset/attenuated types of LSDs.

Program Overview

  • Introduction to the late/adult onset and attenuated forms of LSD's
  • Reports from recent clinitcal studies for LSD's and CNS involvement
  • Basic Research findings to elaborate on underlying mechanisms
  • Recent developments in clinical management and therapeutic guidelines
  • Patient perspectives about diagnostic odyssey
  • Service models in treatment for those with late onset LSD's
  • Advanced therapies and treatment options

LSD's in Focus

  • Fabry's
  • Gaucher
  • Pompe
  • Tay-Sachs
  • Mucopolysaccharidoses (MPS)
  • Niemann-Pick Type C1

Details:

November 18 - 19, 2018
The Marriott Fairfax at Fair Oaks

Connect with us

3959 Pender Drive, Suite 100,
Fairfax VA 22030

  • dummy+1 703-261-6220

  • dummy+1 703 991-6592

  • dummy info@ldrtc.org

Newsletter

Enter your email and we'll send you more information

Search